Keel Point’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
– Sell
-1,815
Closed -$230K – 287
2021
Q3
$230K Buy
1,815
+20
+1% +$2.91K 0.03% 237
2021
Q2
$298K Sell
1,795
-25
-1% -$4.05K 0.03% 201
2021
Q1
$331K Buy
1,820
+17
+0.9% +$3.94K 0.03% 196
2020
Q4
$361K Buy
1,803
+5
+0.3% +$1.02K 0.03% 181
2020
Q3
$394K Buy
+1,798
New +$381K 0.04% 158

Other funds holding TDOC

Keel Point's TDOC Position: Q4 2021 in Review

Keel Point sold out of Teladoc Health (TDOC) in Q4 2021, closing a stake of 1,815 shares — an estimated $230K sold.

Keel Point first reported a position in TDOC in Q3 2020 and held it in 5 quarters. The position peaked at $394K in Q3 2020. 729 funds tracked by Wall St. Rank hold TDOC as of Q4 2021.

  • Keel Point reported no remaining Teladoc Health position as of Q4 2021 after selling out during the quarter.
  • Keel Point sold 1,815 Teladoc Health shares in Q4 2021, an estimated $230K.
  • Keel Point first reported a position in Teladoc Health in Q3 2020 and held it in 5 quarters.
  • Keel Point's Teladoc Health position peaked at $394K in Q3 2020.
  • 729 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2021.

Based on Keel Point's 13F filing for Q4 2021, filed 31 Jan 2022.